Not available
Quote | Sanofi (OTCMKTS:SNYNF)
Last: | $95.45 |
---|---|
Change Percent: | 0.05% |
Open: | $95.45 |
Close: | $95.45 |
High: | $95.45 |
Low: | $95.45 |
Volume: | 357 |
Last Trade Date Time: | 07/02/2024 03:00:00 am |
News | Sanofi (OTCMKTS:SNYNF)
2024-06-30 09:00:00 ET Summary VRNA received FDA approval for ensifentrine (Ohtuvayre) for the maintenance treatment of COPD on June 26. SNY/REGN's Dupixent represents a potential competitor. As do other drugs in development from SNY/REGN and GSK. Verona has the potential for ...
2024-06-29 15:44:55 ET More on Eli Lilly, Novo Nordisk, etc. Novo Nordisk Breaks Out To An All-Time High On China Approval Of Wegovy Eli Lilly: Throwing Its Weight Around - But, For How Long? (Technical Analysis) Eli Lilly: The Party Is Probably Nearing The End ...
Message Board Posts | Sanofi (OTCMKTS:SNYNF)
Subject | By | Source | When |
---|---|---|---|
whytestocks: $SNYNF News Article - Press Release: Sanofi completes acquisition of Provention Bio, In | whytestocks | investorshangout | 04/27/2023 12:55:46 PM |
whytestocks: $SNYNF News Article - Press Release: Nirsevimab: Sanofi, AstraZeneca and Sobi simplify | whytestocks | investorshangout | 04/11/2023 12:25:46 PM |
chartguy89: SNYNF 105.0981 Stock Charts $SNYNF 1 Month Chart | chartguy89 | investorshangout | 03/10/2014 2:57:13 AM |
chartguy89: SNYNF Stock Charts Last: +1.85 Saturday, March 1, 2014 at 5:47:25 PM $SNYNF 1 Mo | chartguy89 | investorshangout | 03/01/2014 10:47:37 PM |
News, Short Squeeze, Breakout and More Instantly...
Audrey Duval Derveloy appointed Global Head of Corporate Affairs, member of Sanofi’s Executive Committee Paris, June 21, 2024 . Audrey Duval Derveloy, a seasoned healthcare industry leader and Sanofi France’s President, has been named Executive Vice President, Global Head ...
ISTH: Sanofi advances leadership in hemophilia with new data for ALTUVIIIO and fitusiran Seven oral presentations across the hemophilia portfolio reinforce Sanofi’s commitment to bring potential first- and best-in-class treatments to the rare blood disorders community Interim r...
Sanofi and Biovac spearhead polio vaccine manufacturing capabilities in Africa Paris, June 20, 2024. Sanofi and Biovac, a Cape Town, South Africa-based biopharmaceutical company, announce today their local manufacturing partnership to produce inactivated polio vaccines (IPV) in Africa. ...